Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center of Excellence for Engineering Biology (CEEB) is a non-profit organization that serves as the administrative and coordinating hub for the Genome Project-write (GP-write). GP-write is a high-profile international research initiative focused on reducing the cost of engineering and testing large genomes, including the human genome, in cell lines. CEEB facilitates multi-disciplinary collaborations between academic institutions, industry partners, and government agencies to advance synthetic biology and genome-scale engineering. The organization's work aims to address global challenges in healthcare, energy, and the environment by developing advanced genetic design and synthesis technologies. By fostering an open-source environment for innovation, CEEB seeks to drive breakthroughs in areas such as virus resistance, organ transplant compatibility, and cell-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center of Excellence for Engineering Biology.